50 Years of Progress in NSCLC: A New Fellow's Guide in the Clinic
Details
Publication Year 2025-10,Volume 20,Issue #10,Page 1392-1422
Journal Title
Journal of Thoracic Oncology
Publication Type
Review
Abstract
In the past 50 years, we have seen a dramatic evolution in thoracic oncology. We have gone from a time of limited understanding of the biology of lung cancer, no demonstrated benefits for screening, and marginal benefits from therapy to an era of molecular profiling, survival benefits from low-dose computed tomography screening, and a steadily expanding list of therapeutic options. Coupled with these advances have been substantial improvements in approaches related to supportive care and end of life. In this state-of-the-art article, the Communications Committee of the International Association for the Study of Lung Cancer presents a comprehensive summary of how some of the major questions in lung cancer were addressed during the last 50 years: from prevention to staging, screening, diagnostics, therapeutics, and supportive care. This is intended to serve as a "survival guide" for new standards in lung cancer care aimed at clinicians and other interested stakeholders, which places these current standards of care in the context of progress in the last 50 years.
Publisher
Elsevier
Keywords
Humans; *Carcinoma, Non-Small-Cell Lung/therapy/history/diagnosis/pathology; *Lung Neoplasms/therapy/diagnosis/history/pathology; 50 Years; Non–small cell lung cancer; Progress; Thoracic Oncology
Department(s)
Radiation Oncology
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-07-31 07:07:39
Last Modified: 2025-11-13 05:53:25
An error has occurred. This application may no longer respond until reloaded. Reload 🗙